Skip to content
Referral program is live — share your code, your friends save 5% and you earn 10% off your next order.
JetStreamPeptides
ADAMAX - 1032 — JetStream Peptides research vial
Neuropeptide Research

ADAMAX - 1032

$90.00

Adamantane-modified Semax analog studied for BDNF/TrkB signaling and blood–brain barrier penetration.

Purity
>99%
Testing
3rd-party
Shipping
Tracked, discreet
$90.00In stock
Size
1
For laboratory research use only. Not for human consumption. Full disclaimer

1 lab report (COA) available for this product.

About ADAMAX - 1032

Next-generation Semax analog. Enhanced BBB penetration and neurotrophic research.

Adamax is a synthetic heptapeptide analog of Semax, structurally modified with N-acetyl protection and an adamantane group at the N-terminus. These dual modifications confer significantly greater enzymatic stability and lipophilicity compared to parent Semax analogs, resulting in enhanced resistance to proteolytic degradation and improved blood-brain barrier (BBB) penetration. Adamax is studied in preclinical models for its role in BDNF upregulation, TrkB receptor sensitivity, and neurotrophic signaling — with the adamantane modification providing a more sustained CNS bioavailability profile than unmodified Semax.

Research applications

  • BDNF expression modulation and TrkB receptor sensitivity research in hippocampal models
  • Enhanced BBB penetration and CNS bioavailability pharmacokinetics studies
  • Neurotrophic signaling and neuroplasticity pathway investigation
  • HGF/c-Met receptor pathway potentiation and downstream signaling research
  • Enzymatic stability and proteolytic resistance of adamantane-modified peptides

Lab reports (COA)

Independent third-party test results for ADAMAX - 1032, newest first.

BatchTestedLabPurityReport
PGB-ADMX10-1Jun 5, 2026Janoshik (PGB group test)99.63%View COA

More in Neuropeptide Research